HomeCLYYF • OTCMKTS
add
Celyad Oncology SA
Previous close
$0.35
Year range
$0.15 - $0.53
Market cap
14.28M EUR
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 3.50K | -95.93% |
Operating expense | -1.11M | -175.40% |
Net income | 2.25M | 262.05% |
Net profit margin | 64.36K | 4,081.81% |
Earnings per share | — | — |
EBITDA | 1.16M | 186.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.71M | -59.33% |
Total assets | 4.30M | -56.71% |
Total liabilities | 1.86M | -80.23% |
Total equity | 2.44M | — |
Shares outstanding | 46.11M | — |
Price to book | 7.00 | — |
Return on assets | 65.00% | — |
Return on capital | 114.69% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 2.25M | 262.05% |
Cash from operations | -1.81M | -27.27% |
Cash from investing | 1.50M | 19,946.67% |
Cash from financing | 765.00K | 89.36% |
Net change in cash | 455.50K | 144.90% |
Free cash flow | 555.94K | 178.94% |
About
Founded
2004
Headquarters
Website
Employees
1
